Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.

Publikation

Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.

Wissenschaftlicher Artikel/Review - 11.04.2024

Mokbel Sara, Baciarello Giuilia, Lavaud Pernelle, Omlin Aurelius, Calabrò Fabio, Cathomas Richard, Aeppli Stefanie, Parent Pauline, Giannatempo Patrizia, Koster Kira-Lee, Appel Naara, Gonnet Philippe, Angius Gesuino, Tsantoulis Petros, Arkenau Hendrick-Tobias, Cattrini Carlo, Messina Carlo, Zeghondy Jean, Morelli Cristina, Loriot Yohann, Formica Vincenzo, Patrikidou Anna

Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.

Formica, Vincenzo

Patrikidou, Anna